1Neaton JD, Black bum H, Jacobs D, et al. Serum cholesterol and mortality findings for men ~reened in the Multiple Risk Factor Interveniton Trial. Arch Intern Med, 1992, 152:1490-1500.
2Vershuren WMM,Jacobs DR,Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures, twenty-five year follow-up of the seven countries study. JAMA. 1995,274:131-136.
3National cholesterol education program. Second report of the expert panel on detection, Evaluation and Treatment of high blood cholesterol in Adults (Adult treatment panel ( Ⅱ ))circulation. 1990,81:1721-1733.
4Marcelino J J, Feingold KR. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. AMJ Med, 1996,100:605-610.
5Nawrocki JW, Weiss SR, Davidson ME, et al. Reduction of LDL cholesterol by 25 % to 60 % in patients with primary hypercholesolemia by atorvastatin, a new HMG-CoAreductase inhibitor. Arterioscler Thromb Vasc Biol, 1995,678-682.
